Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
06 2022
Historique:
revised: 21 02 2022
received: 19 01 2022
accepted: 01 03 2022
pubmed: 4 3 2022
medline: 22 4 2022
entrez: 3 3 2022
Statut: ppublish

Résumé

To determine the serum bile acid (BA) response to 75-g oral glucose in individuals without diabetes, and whether this is attenuated in patients with 'early' type 2 diabetes (T2D) and related to the glycaemic response at 2 hours in either group. Forty newly diagnosed, treatment-naïve Han Chinese T2D subjects and 40 age-, gender-, and body mass index-matched controls without T2D ingested a 75-g glucose drink after an overnight fast. Plasma glucose and serum concentrations of total and individual BAs, fibroblast growth factor-19 (FGF-19), total glucagon-like peptide-1 (GLP-1), and insulin, were measured before and 2 hours after oral glucose. Fasting total BA levels were higher in T2D than control subjects (P < .05). At 2 hours, the BA profile exhibited a shift from baseline in both groups, with increases in conjugated BAs and/or decreases in unconjugated BAs. There were increases in total BA and FGF-19 levels in control (both P < .05), but not T2D, subjects. Plasma glucose concentrations at 2 hours related inversely to serum total BA levels in control subjects (r = -0.42, P = .006). Total GLP-1 and the insulin/glucose ratio were increased at 2 hours in both groups, and the magnitude of the increase was greater in control subjects. The serum BA response to a 75-g oral glucose load is attenuated in patients with 'early' T2D, as is the secretion of FGF-19 and GLP-1, while in individuals without T2D it correlates with 2-hour plasma glucose levels. These observations support a role for BAs in the regulation of postprandial glucose metabolism.

Identifiants

pubmed: 35238131
doi: 10.1111/dom.14683
pmc: PMC9540586
doi:

Substances chimiques

Bile Acids and Salts 0
Blood Glucose 0
Insulin 0
Fibroblast Growth Factors 62031-54-3
Glucagon-Like Peptide 1 89750-14-1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1132-1142

Informations de copyright

© 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Références

Diabetes. 2015 Jul;64(7):2513-25
pubmed: 25677912
Metabolism. 2019 Apr;93:25-32
pubmed: 30658059
Nat Commun. 2015 Jul 21;6:7715
pubmed: 26197299
Nat Commun. 2021 Mar 5;12(1):1487
pubmed: 33674561
Front Neurosci. 2015 Jun 03;9:199
pubmed: 26089773
Gastroenterology. 2019 Mar;156(4):1041-1051.e4
pubmed: 30445014
J Clin Endocrinol Metab. 2013 Apr;98(4):E718-22
pubmed: 23418316
J Clin Endocrinol Metab. 2016 May;101(5):1935-44
pubmed: 26684275
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9
pubmed: 25470627
J Lipid Res. 2011 Aug;52(8):1561-8
pubmed: 21642744
Diabetes. 2014 Aug;63(8):2776-87
pubmed: 24647737
J Lipid Res. 2012 Oct;53(10):2231-2241
pubmed: 22822028
Ann Clin Biochem. 2010 Sep;47(Pt 5):482-4
pubmed: 20595403
J Intern Med. 2017 May;281(5):507-517
pubmed: 28261926
Diabetes Care. 2015 Feb;38(2):243-8
pubmed: 25504029
Diabetes Obes Metab. 2022 Jun;24(6):1132-1142
pubmed: 35238131
Int J Obes (Lond). 2017 May;41(5):789-792
pubmed: 28104918
EBioMedicine. 2020 May;55:102759
pubmed: 32344198
Cell Metab. 2019 Nov 5;30(5):855-864.e3
pubmed: 31588013
PLoS One. 2011;6(11):e25006
pubmed: 22110577
Gastroenterology. 2017 May;152(7):1679-1694.e3
pubmed: 28214524
Clin Chem. 2016 Sep;62(9):1211-9
pubmed: 27471037
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1643-e1652
pubmed: 34791325
Diabetes Obes Metab. 2020 Feb;22(2):141-148
pubmed: 31468642
Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G413-9
pubmed: 23275610
Prog Lipid Res. 2021 Apr;82:101094
pubmed: 33636214
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2020-30
pubmed: 16037564
J Lipid Res. 2010 Apr;51(4):832-42
pubmed: 19965590
Eur J Endocrinol. 2014 Oct;171(4):407-19
pubmed: 24986531
J Pharm Biomed Anal. 2016 Nov 30;131:473-481
pubmed: 27689719
Nat Rev Endocrinol. 2019 Dec;15(12):701-712
pubmed: 31616073
Cell Metab. 2009 Sep;10(3):167-77
pubmed: 19723493
Diabetes Care. 2021 Feb;44(2):499-510
pubmed: 33355246
Nutrients. 2021 Mar 28;13(4):
pubmed: 33800566
Handb Exp Pharmacol. 2016;233:137-71
pubmed: 25903418
Ann Clin Biochem. 2013 Jul;50(Pt 4):360-4
pubmed: 23771134
United European Gastroenterol J. 2014 Jun;2(3):216-25
pubmed: 25360305
J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
pubmed: 10902785
Obes Surg. 2016 Jul;26(7):1565-75
pubmed: 26464241
Endocrinology. 2015 Nov;156(11):3961-70
pubmed: 26280129
Handb Exp Pharmacol. 2019;256:51-72
pubmed: 31230143
Essays Biochem. 2016 Dec 15;60(5):409-418
pubmed: 27980091
Pharmaceutics. 2020 Aug 21;12(9):
pubmed: 32825608
J Clin Endocrinol Metab. 2016 Aug;101(8):3002-9
pubmed: 27270475

Auteurs

Xuyi Wang (X)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.
Department of Clinical Nutrition, Southeast University, Nanjing, China.

Chang Chen (C)

Institute of Life Sciences, Chongqing Medical University, Chongqing, China.

Cong Xie (C)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.

Weikun Huang (W)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.

Richard L Young (RL)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.
Nutrition, Diabetes & Gut Health, Lifelong Health Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.

Karen L Jones (KL)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide.

Michael Horowitz (M)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide.

Christopher K Rayner (CK)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.
Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia.

Zilin Sun (Z)

Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing.

Tongzhi Wu (T)

Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide.
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH